Key result
Continuous SVO2 monitoring guides perioperative management in 57% of cardiac surgery patients.
Why the study?
The study aimed to identify cardiac surgery patients in whom fiberoptic pulmonary artery catheter oximetry for continuous mixed venous oxygen saturation monitoring would be most useful.
What are the predictive factors for the usefulness of continuous SVO2 monitoring via fiberoptic PAC in cardiac surgery patients?
Observational (n=286)
Single-blind
What are the predictive factors for the usefulness of continuous SVO2 monitoring via fiberoptic PAC in cardiac surgery patients?
Relative Risk: 1.78 (95% CI 1.51–2.07)
p-value: p=< 10-5
Continuous SVO2 monitoring via fiberoptic PAC is most useful in cardiac surgery patients with high severity of illness, specifically those with ASA class ≥4, NYHA score ≥3, or undergoing mitral surgery.
Supports selective SVO2 monitoring in high-severity cardiac surgery cases; leaves open outcome benefits pending randomized confirmation.
The main goal of this prospective study was to identify among cardiac surgery patients, usually monitored through a standard pulmonary artery catheter (PAC), those in whom a fiberoptic catheter oximeter to measure oxygen saturation in mixed venous blood (SVO2 PAC) would be most useful.Data from 286 patients who underwent coronary artery bypass graft (50%) or valvular surgery were recorded, including ASA physical status, New York Heart Association (NYHA) classification, and Parsonnet score (PS). Hemodynamic events and SVO2 changes were collected intra- and postoperatively until weaning from mechanical ventilation. The anesthesiologist in charge graded the usefulness of SVO2 PAC, and another anesthesiologist carried out a blindly controlled overall evaluation. Usefulness was defined as the presence of a change in therapeutic maneuver triggered solely by continuous SVO2 data that would not have occurred based on other routine parameters. SVO2 was also considered useful if earlier recognition of significant adverse events occurred. SVO2 PAC was useful in 57% of the patients. Independent predictive factors (multivariate analysis) for the perioperative usefulness of SVO2 in the whole population consisted of ASA class >or=to4 (P < 10-5; relative risk [RR] 1.78, 1.51-2.07), mitral surgery (P < 10-4; RR 1.72, 1.4-2.02), and NYHA score >or=to3 (P < 0.01; RR 1.66, 1.35-2.05). Independent predictive factors for the perioperative usefulness of SVO2 in the coronary artery bypass graft population were NYHA score >or=to 3 (P < 10-5; RR 1.90, 1.42-2.55) and ASA class >or=to 4 (P < 0.01; RR 1.99, 1.51-2.63). The presence of three stenosed coronary arteries showed borderline significance (P < 0.06), Independent predictive factors for perioperative usefulness of SVO2 in the valvular population were mitral pathology (P < 10-5) and ASA class >or=to 4 (P < 0.01). The receiver operator characteristic curve assessed the predictivity of the PS. SVO2 PAC was more useful in the group of patients with the greatest severity of illness (PS in useful group 17.0 +/- 10.3; in nonuseful group 8.7 +/- 6.6; P < 10-4). Intensive care unit duration and hospital stay in the useful group was prolonged compared with the nonuseful group. Similarly, morbidity was frequent in the useful group, although it was not always significantly different from the nonuseful group according to the type of complications. Mortality was comparable in the groups despite their different degree of illness and was reduced when taking into account the predictive and observed mortality provided by the PS. This study defined independent preoperative factors associated with SVO2 PAC monitoring and proposed a cutoff point above which SVO2 may be useful. (Anesth Analg 1997;85:2-10)
No takes yet. Share an insight, caveat, or question.
Védrinne et al. (1997) conducted an observational in Cardiac surgery (n=286). High surgical risk (ASA class >=4, NYHA score >=3, mitral surgery) vs. Lower surgical risk was evaluated on Perioperative usefulness of SVO2 PAC (change in therapy or earlier recognition of adverse events) (RR 1.78, 95% CI 1.51-2.07, p=< 10-5). Continuous SVO2 monitoring was useful in 57% of cardiac surgery patients, with ASA class ≥4 (RR 1.78; 95% CI 1.51-2.07) and NYHA score ≥3 identified as independent predictive factors.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: